PDE4A and myeloid sarcoma: In addition to an anti-neuroinflammatory effect in MS, pan-PDE4 inhibition has also been found to stimulate remyelination through an effect on oligodendrocyte precursor cell (OPC) differentiation, which is explained in more detail in the review by Schepers et al. [142].